OverviewChartNewsTraderScreen

Soc. Generale Discount Zert PBB 2.../  DE000SV9KEX6  /

Frankfurt Zert./SG
2024-05-31  9:48:03 PM Chg.-0.020 Bid9:52:26 PM Ask- Underlying Strike price Expiration date Option type
5.650EUR -0.35% 5.670
Bid Size: 2,000		 -
Ask Size: -		 DT.PFANDBRIEFBK AG - EUR 2024-06-28 Call
GlobeNewswire 7:39 PM QuidelOrtho (QDEL) Investors Who Suffered Substantial Losses After QDEL Reported Disastrous Q4 2023 ...
TeleTrader 7:09 PM US upset by Israel's response to Biden's ceasefire proposal
GlobeNewswire 7:02 PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pret...
TeleTrader 6:27 PM N. Korea sends trash-filled balloons to South
TeleTrader 5:37 PM Hezbollah rockets strike Israeli base in northern Israel
TeleTrader 5:02 PM Israel's Lapid slams government over post-war plan
Newsfile Corp 5:00 PM WATCH by Aisles: A Revolutionary AI System for Public Safety
TeleTrader 4:16 PM Belgium condemns Israel's bid to label UNRWA as terrorist
GlobeNewswire 4:00 PM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstr...
GlobeNewswire 4:00 PM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...
GlobeNewswire 4:00 PM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...
TeleTrader 3:23 PM Macron backs Biden's ceasefire proposal for Gaza
GlobeNewswire 3:14 PM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
GlobeNewswire 3:00 PM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Ther...
GlobeNewswire 3:00 PM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monothera...
TeleTrader 2:35 PM ANC loses 30-year majority in S. Africa
GlobeNewswire 2:15 PM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with ...
GlobeNewswire 2:15 PM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
GlobeNewswire 2:05 PM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
GlobeNewswire 2:00 PM Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages...
GlobeNewswire 2:00 PM Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonst...
GlobeNewswire 2:00 PM Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin)...
GlobeNewswire 2:00 PM OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
GlobeNewswire 2:00 PM Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at...
GlobeNewswire 2:00 PM CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes